Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.3_suppl.207
Abstract: 207 Background: Tumor sidedness is a prognostic factor and predictive parameter for EGFR monoclonal antibody (mAb) treatment in mCRC. Sidedness is believed to be a surrogate for genomic differences. This study aimed to evaluate genomics… read more here.
Keywords: genomics sidedness; tumor genomics; sidedness; mcrc ... See more keywords